Laddar…
CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
Background: Triple negative breast cancers (TNBCs) are an aggressive BC subtype, characterized by high rates of drug resistance and a high proportion of cancer stem cells (CSC). CSCs are thought to be responsible for tumor initiation and drug resistance. cAMP-response element-binding (CREB) binding...
Huvudupphovsmän: | , , , , , , , |
---|---|
Materialtyp: | Online Artikel Text |
Språk: | English |
Publicerad: |
MDPI
2018
|
Ämnen: | |
Länkar: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315782/ https://www.ncbi.nlm.nih.gov/pubmed/30572639 http://dx.doi.org/10.3390/cancers10120525 |